Currently, over 6 million Americans are afflicted with Alzheimer’s disease (AD), a figure expected to double by 2050. The financial impact is staggering, with costs in the U.S. reaching $345 billion in 2023 and potentially nearing $1 trillion by 2050. Beyond numbers, Alzheimer’s Disease is deeply affecting patients, caregivers, and families, both emotionally and socially. The scarcity of adequate medical resources exacerbates these challenges. According to the Alzheimer’s Association, the primary workforce supporting dementia patients comprises direct care workers. Additionally, the last decade has seen a high failure rate in Alzheimer’s drug development, with a 99.6% attrition rate recorded between 2002 and 2012.
However, the recent advances in drug development offer potential treatments that could slow the disease’s progression in its early stages. These new drugs signify a shift in approach, introducing new therapeutic options for a previously underserved patient group. Health technology is poised to play a crucial role in this shift, aiding in patient identification, early diagnosis, disease monitoring, and daily support for patients and caregivers.
In this white paper, we address the various challenges and pain points Alzheimer’s Disease presents for affected patients. We will explore how digital health solutions can mitigate these challenges and discuss the impact and value of digital health in the realm of Alzheimer’s Disease. The paper will also detail how Aptar Digital Health plans to enhance the lives of those living with Alzheimer’s Disease.
"*" indicates required fields